Marcus Ruscetti

16PUBLICATIONS

85CO-AUTHORS

Tumour immunologyHaematological tumoursMolecular targetsPredictive and prognostic markersCancer cell biology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|Jun 19, 2026

Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancer.

|Mar 26, 2026

Tumor Homing Nanoparticle Immunotherapy for Acute Clearance and Mitigation of T-cell Exhaustion in Humanized High-Risk Neuroblastoma.

Griffin I Kane, Miranda B Diaz-Infante, Kim Wigglesworth

|Dec 09, 2025

Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression.

Suresh Chava, Suresh Bugide, Parmanand Malvi

|Oct 24, 2025

p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy.

Lin Zhou, Kelly D DeMarco, Katherine C Murphy

|Sep 22, 2025

PPT1 is a negative regulator of STING signaling in cancer cells and its inhibition reactivates immune surveillance in cold tumors.

Shreya R Chowdhury, Chaitanya N Parikh, Arshia N Kaur

|Sep 03, 2025

MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T-cell and Immunotherapy Responses in Prostate Cancer.

Katherine C Murphy, Kelly D DeMarco, Lin Zhou

Pageof 3

Frequent Collaborators

Lihua Julie Zhu

Katherine C Murphy

Jason R Pitarresi

Kelly D DeMarco

Karl Simin

Lin Zhou

Junhui Li

Prabhani U Atukorale

Meghan L Brassil

Scott W Lowe

Frequent Collaborators

Lihua Julie Zhu

Katherine C Murphy

Jason R Pitarresi

Kelly D DeMarco